1Yamanaka H,
Matsuda Y,
Tanaka M,
Sendo W,
Nakajima H,
Taniguchi A, et al.
Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis.
Arthritis Rheum2000;
43:
852–8.
2Manicourt D-H,
Fujimoto N,
Obata KI,
Thonar EJ-MA.
Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis: relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation.
Arthritis Rheum1995;
38:
1031–9.
3Keyzer G,
Lambiri I,
Nagel R,
Keysser C,
Keysser M,
Gromnica-Ihle E, et al.
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease: correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
J Rheumatol1999;
26:
251–8.
4Larsen A,
Dale K,
Eek M.
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.
Acta Radiol1977;
18:
481–91.
6Cheung NT,
Dawes PT,
Poulton KV,
Ollier WER,
Taylor DJ,
Mattey DL.
High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis.
J Rheumatol2000;
27:
882–7.
Please check your email for instructions on resetting your password.
If you do not receive an email within 10 minutes, your email address may not be registered,
and you may need to create a new Wiley Online Library account.
Request Username
Can't sign in? Forgot your username?
Enter your email address below and we will send you your username
If the address matches an existing account you will receive an email with instructions to retrieve your username
The full text of this article hosted at iucr.org is unavailable due to technical difficulties.
43:11<2614::aid-anr36>3.0.co;2-h.fp.png)
